News

News about our portfolio and KREAXI

Nosopharm bolsters supervisory board

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, today announces the appointment of Marie-Paule Richard and Gilles Alberici to its supervisory board. Alberici will be its new chairman. These new appointees will strengthen...

Symetis and Boston Scientific reach USD 435 million purchase agreement

- Definitive purchase agreement whereby Boston Scientific will acquire Symetis for $435 million in an all cash, up-front payment - Acquisition of Symetis will expand the treatment offerings for patients with aortic valvular heart disease - Acquisition projected to...